Volume 5, Issue 1 (5-2017)                   Jorjani Biomed J 2017, 5(1): 31-25 | Back to browse issues page

XML Persian Abstract Print


1- Pediatric Cardiology, Tabriz University of Medical Sciences, Tabriz-Iran.
2- Subspecialist of pediatric heart disease, Associate Professor of Pediatric Cardiology, Tabriz University of Medical Sciences, Tabriz-Iran. , medicalresearchtbz@gmail.com
3- Assistant of Pediatrics, Department of Pediatric Disease, Tabriz University of Medical Sciences, Tabriz-Iran.
4- Subspecialist of Neonates, Department of Pediatric Disease, Urmia University of Medical Sciences, Urmia-Iran.
5- Researcher of Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:   (10937 Views)
Background & Objective: Pulmonary Arterial Hypertension (PAH) is one of the common complications of congenital heart diseases in children. The natriuretic peptides such as BNP, ANP and NT-Pro BNP are secreted in response to atrial and/or ventricular stretch. The aim of this study was to evaluate the correlation between pulmonary hypertension with BNP serum level and the quantity of left to right shunt based on echocardiography findings in children with congenital heart disease.
Method: In an analytical-descriptive study, 30 children with congenital heart disease after going through echocardiography and being confirmed to have one of VSD, ASD or PDA, were enrolled. The BNP serum level, quantity of the left to right shunt and systolic pulmonary pressure were measured.
Results: In the present study, 13 patients were male (43.3%) and 17 (56.7%) were female. The average BNP serum level of patients was 194.9 ± 21.2 (pg/ml). There was a significant relationship between systolic pulmonary pressure and BNP level among patients (P<0.001). There was also a positive correlation between average serum level of BNP and quantity of the left to right shunt (P=0.018).
Conclusion: On the basis of echocardiography findings, there was a positive correlation between systolic pulmonary pressure with BNP serum level and the quantity of left to right shunt. Therefore, it can be helpful among patients whom the pulmonary arterial pressure cannot be measured for any reason.
Full-Text [PDF 706 kb]   (4288 Downloads)    
Type of Article: Original article |
Received: 2017/09/27 | Accepted: 2017/09/27 | Published: 2017/09/27

References
1. 1. D'Alto, Michele, and Vaikom S. Mahadevan. "Pulmonary arterial hypertension associated with congenital heart disease." European Respiratory Review21.126 (2012): 328-337 [Article]
2. 2. Kasahara, S. "[Congenital heart disease having left to right shunts combined with pulmonary hypertension]." Kyobu geka. The Japanese journal of thoracic surgery 65.8 (2012): 660-664 [Article]
3. 3. Cevik, Ayhan, et al. "Left-to-Right Shunt with Congenital Heart Disease: Single Center Experience." ISRN cardiology 2013 (2013) [Article]
4. 4. Gatzoulis, Michael A., et al. "Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions." International journal of cardiology 177.2 (2014): 340-347 [Article]
5. 5. Hutchinson, Kirk R., et al. "Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure."Journal of Applied Physiology 111.6 (2011): 1778-1788 [Article]
6. 6. Rondelet, Benoit, et al. "Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure." European heart journal 33.8 (2012): 1017-1026 [Article]
7. 7. Palmer, Biff F. "Pathogenesis of ascites and renal salt retention in cirrhosis."Journal of investigative medicine: the official publication of the American Federation for Clinical Research 47.5 (1999): 183-202 [Article]
8. 8. Jalan, Rajiv, et al. "Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS)."European journal of gastroenterology & hepatology 8.11 (1996): 1111-1116 [Article]
9. 9. Gilboa, Suzanne M., et al. "Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006." Circulation122.22 (2010): 2254-2263 [Article]
10. 10. Bolger, Aidan P., et al. "Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease." Circulation 106.1 (2002): 92-99 [Article]
11. 11. Book, Wendy M., Brenda J. Hott, and Michael McConnell. "B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure." The American journal of cardiology 95.4 (2005): 545-546 [Article]
12. 12. Tulevski, I. I., et al. "Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction." Heart 86.1 (2001): 27-30 [Article]
13. 13. Law, Yuk M., et al. "Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease." The American journal of cardiology 95.4 (2005): 474-478 [Article]
14. 14. Schwachtgen, L., et al. "Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children." Zeitschrift für Kardiologie 94.6 (2005): 399-404 [Article]
15. 15. Nir, A., et al. "N‐terminal pro‐B‐type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases." Acta Paediatrica 93.5 (2004): 603-607 [Article]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.